Natco Pharma Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹647.30 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 52.51 per cent from ₹1,363.00 crore. This corresponds to a year-on-year *(YoY) growth of 36.33 per cent.
Operating Profit
Operating Profit stands at ₹158.70 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 72.60 per cent from ₹579.20 crore. This corresponds to a year-on-year *(YoY) growth of 309.02 per cent.
PBDT
PBDT stands at ₹218.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 67.24 per cent from ₹666.10 crore. This corresponds to a year-on-year *(YoY) growth of 3.56 per cent.
Profit Before Tax
Profit Before Tax stands at ₹172.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 71.97 per cent from ₹613.70 crore. This corresponds to a year-on-year *(YoY) growth of 5.07 per cent.
Net Profit
Net Profit stands at ₹151.30 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 70.79 per cent from ₹517.90 crore. This represents a 14.27 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Natco Pharma Ltd News
Natco Pharma Ltd Earnings
- YOY
- QOQ
Natco Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Natco Pharma Ltd Research Reports
Natco Pharma Ltd Financial Reports
Natco Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Natco Pharma | 1.32% | 0.22% | 9.27% | 31.02% | 38.98% | 33.00% |
| Neuland Labs. | 0.60% | 2.14% | 11.57% | 22.16% | 2.58% | 49.39% |
| OneSource Speci. | -0.51% | 2.94% | 5.29% | 40.58% | 16.50% | 10.29% |
| Pfizer | -0.79% | -4.14% | -2.58% | -8.12% | -6.35% | -9.50% |
| ERIS Lifescience | -6.46% | 3.63% | -0.27% | 2.79% | -17.41% | -7.85% |
| Granules India | 0.64% | 4.34% | 11.14% | 27.48% | 43.31% | 47.40% |
| Cohance Life | 0.12% | -2.10% | 15.57% | 33.75% | -26.34% | -61.19% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : V C Nannapaneni
Vice Chairman & Chief Executive Officer : Rajeev Nannapaneni
ED / EVP : PSRK Prasad
ED / President : D Linga Rao
Independent Non Exe. Director : A D Murthy Chavali
Independent Non Exe. Director : Vijayabhaskar Dronadula
Independent Non Exe. Director : B. Lakshminarayana
Independent Non Exe. Director : Kantipudi Suma
Independent Non Exe. Director : Nitin Jain
Company Sec. & Compli. Officer : Chekuri Venkat Ramesh